Prescription drug · NDA
Gallium Ga-68 PSMA-11 (gallium ga-68 gozetotide) NDC 24275-0525
Gallium ga-68 gozetotide 5 mCi/mL · Injection, Solution · Intravenous · UCSF Radiopharmaceutical Facility
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24275-0525-1 | 24275052501 | 11 mL in 1 VIAL, MULTI-DOSE (24275-0525-1)Marketed from Dec 14, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gallium Ga-68 PSMA-11
- Generic name (nonproprietary)
- gallium ga-68 gozetotide
- Active ingredients
- Gallium ga-68 gozetotide — 5 mCi/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 212643
- Marketing start
- Listing expires
- Other FDA classes
- Positron Emitting Activity (Mechanism)
- Identifiers
- Product ID 24275-0525_4395a8f3-f489-e90c-e063-6294a90a7ae5SPL ID 4395a8f3-f489-e90c-e063-6294a90a7ae5SPL set ID b6253a7b-0f73-36be-e053-2a95a90a9015UNII ZJ0EKR6M10
- Pharmacologic class
- Radioactive Diagnostic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N424275052501followed by a unit qualifier and the quantityPackage 24275-0525-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Gallium Ga 68 Gozeotide Injection is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. Gallium Ga 68 Gozetotide Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. with suspected recurrence based on elevated serum prostate-specific ant…
Excerpt only. Read the full label for complete information.